A new class of simplified phorbol ester analogues: Synthesis and binding to PKC and ηPKC-C1B (ηPKC-CRD2)

Organic Letters

Volumn 1, Issue 7, 1999, Pages 1009-1012

  Wender, Paul A ^a   Kirschberg, Thorsten A ^a   Williams, Peter D ^a   Bastiaans, Harold M M ^a   Irie, Kazuhiro ^b  

^a STANFORD UNIVERSITY   (United States)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PHORBOL ESTER; PROTEIN KINASE C;

ANIMAL; ARTICLE; ENZYME SPECIFICITY; METABOLISM; MOUSE; RAT; SYNTHESIS;

ANIMALS; MICE; PHORBOL ESTERS; PROTEIN KINASE C; RATS; SUBSTRATE SPECIFICITY;

EID: 0033533637     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol990809k     Document Type: Article

References (50)

1. (a) Evans, F. J., Ed. Naturally Occurring Phorbol Esters; CRC Press: Boca Raton, FL, 1986.
2. (b) Hecker, E.; Schmidt, R. Fortschr. Chem. Org. Naturst. 1974, 31, 377-467.
3. (c) Blumberg, P. M. Cancer Res. 1988, 48, 1-8.
4. (d) Marks, F.; Gschwendt, M. Mutation Res. 1995, 333, 161-172.
5. (a) Nishizuka, Y. Science 1986, 233, 305-312.
6. (b) Liu, J.-P. Mol. Cellular Endocrinol., 1996, 116, 1-29.
7. (c) Farley, J.; Auerbach, S. Nature 1986, 319, 220-223.
8. (d) Leon, J. A.; Goldstein, N. I.; Fisher, P. B. Pharmacol. Ther. 1994, 61, 237-278.
9. (a) Nishizuka, Y. Nature 1988, 334, 661-665.
10. (b) Lester, D. S., Epand R. M., Eds. Protein Kinase C Current Concepts and Future Perspectives; Ellis Horwood: West Sussex, 1992.
11. (c) Kuo, J. F., Ed. Protein Kinase C; Oxford University Press: New York, 1994.
12. (d) Newton, A. C. J. Biol. Chem. 1995, 270, 28495-28498.
13. (e) Nishizuka, Y. FASEB J. 1995, 9, 484-496.
14. (a) Wender, P. A.; Cribbs, C. M.; Koehler, K. F.; Sharkey, N. A.; Herald, C. L.; Kamano, Y.; Pettit, G. R.; Blumberg, P. M. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 7191-7201.
15. (b) Wender, P. A.; Irie, K.; Miller, B. L. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 239-243.
16. (c) Slater, S. J.; Ho, C.; Kelly, M. B.; Larkin, J. D.; Tasseo, F. J.; Yeager, M. D.; Stubbs, C. D. J. Biol. Chem. 1996, 271, 4627-4631.
17. For examples of structure-activity studies, see: (a) Kazanietz, M. G.; Araces, L. B.; Bahador, A.; Mischak, H.; Goodnight, J.; Mushinski, J. F.; Blumberg, P. M. Mol. Pharmacol. 1993, 44, 298-307.
18. (b) Zhang, G.; Kazanietz, M. G.; Blumberg, P. M.; Hurley, J. H. Cell 1995, 81, 917-924.
19. (c) Irie, K.; Ishii, T.; Ohigashi, H.; Wender, P. A.; Miller, B. L.; Takeda, N. J. Org. Chem. 1996, 61, 2164-2173.
20. (d) Sodeoka, M.; Arai, M. A.; Adachi, K.; Uotsu, K.; Shibasaki, M. J. Am. Chem. Soc. 1998, 120, 457-458.
21. (e) Winkler, J. D.; Kim, S.; Harrison, S.; Lewin, N. E.; Blumberg, P. M. J. Am. Chem. Soc. 1999, 121, 296-300.
22. (a) Wender, P. A.; Lee, H. Y.; Wilhelm, R. S.; Williams, P. D. J. Am. Chem. Soc. 1989, 111, 8954-8957.
23. (b) Wender, P. A.; Kogen, H.; Lee, H. Y.; Munger J. D. Jr.; Wilhelm, R. S.; Williams, P. D. J. Am. Chem. Soc. 1989, 8957-8958.
24. (c) Wender, P. A.; McDonald, F. E. J. Am. Chem. Soc. 1990, 112, 4956-4958.
25. (d) Wender, P. A.; Rice, K. D.; Schnute, M. E. J. Am. Chem. Soc. 1997, 119, 7897-7898.
26. For other approaches to the synthesis of phorbol or phorbol analogues, see: (a) Tokunoh, R.; Tomiyama, H.; Sodeoka, M.; Shibasaki, M. Tetrahedron Lett. 1996, 37, 2449-2452.
27. (b) Sugita, K.; Sawada, D.; Sodeoka, M.; Sasai, H.; Shibasaki, M. Chem. Pharm. Bull. 1996, 44, 463-465.
28. (c) Sugita, K.; Neville, C. F.; Sodeoka, M.; Sasai, H.; Shibasaki, M. Tetrahedron Lett. 1995, 36, 1067-1070.
29. (d) Sugita, K.; Shigeno, K.; Neville, C. F.; Sasai, H.; Shibasaki, M. Synlett 1994, 325-329.
30. (e) Brickwood, A. C.; Drew, M. G. B.; Harwood, L. M.; Ishikawa, T.; Marais, P.; Morisson, V. J. Chem. Soc., Perkin Trans. 1 1999, 913-921.
31. (f) Page, P. C. B.; Jennens, D. C.; McFarland, H. Tetrahedron Lett. 1997, 38, 5395-5398.
32. (g) McMills, M. C.; Zhuang, L.; Wright, D. L.; Watt, W. Tetrahedron Lett. 1994, 35, 8311-8314.
33. (h) Paquette, L. A.; Sauer, D. R.; Edmondson, S. D.; Friedrich, D. Tetrahedron 1994, 50, 4071-4086.
34. (i) Dauben, W. G.; Dinges, J.; Smith, T. C. J. Org. Chem. 1993, 58, 7635-7637.
35. (j) Rigby, J. H.; Kierkus, P. C. J. Am. Chem. Soc. 1989, 111, 4125-4126.
36. (a) Irie, K.; Yanai, Y.; Ohigashi, H.; Wender, P. A.; Miller. B. L. Bioorg. Med. Chem. Lett. 1996, 6, 353-356.
37. (b) Yanai, Y.; Irie, K.; Ohigashi, H.; Wender, P. A. Bioorg. Med. Chem. Lett. 1997, 7, 117-122.
38. (c) Irie, K.; Oie, K.; Nakahara, A.; Yanai, Y.; Ohigashi, H.; Wender, P. A.; Fukuda, H.; Konishi, H.; Kikkawa, U. J. Am. Chem. Soc. 1998, 120, 9159-9167. See also ref 4b.
39. For leading references, see: (a) Jeffrey, A. M.; Liskamp, R. M. J. Proc. Natl. Acad. Sci. U.S.A. 1986, 83, 241-245.
40. (b) Wender, P. A.; Koehler, K. F.; Sharkey, N. A.; Dell'Aquila, M. L.; Blumberg, P. M. Proc. Natl. Acad. Sci. U.S.A. 1986, 83, 4214-4218.
41. (c) Itai, A.; Kato, Y.; Tumioka, N.; Iitaka, Y.; Endo, Y.; Hasegawa, M.; Shudo, K.; Fujiki, H.; Sakai, S.-I. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 3688-3692.
42. (d) Nakamura, H.; Kishi, Y.; Pajares, M. A.; Rando, R. R. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 9672-9676.
43. The use of NaOAc was found to be essential for efficient dibromide formation. Unambiguous stereochemical assignment of C6 by NMR spectroscopy was not possible.
44. All new compounds were fully characterized spectroscopically. The identity of the dibromide was further proven by elemental analysis.
45. Driedger, P. E.; Blumberg, P. M. Proc. Natl. Acad. Sci. U.S.A 1980, 77, 567-571.
46. (a) Phorbol numbering is used for all derivatives. (b) The ability of the C9 hydroxyl to act as a coordinating/activating group in a related stereoselective ketone reduction has been utilized in the total synthesis of phorbol: see ref 6b.
47. See ref 1b.
48. Hibino, J.; Okazoe, T.; Takai, K.; Nozaki, H. Tetrahedron Lett. 1985, 26, 5579-5580.
49. Tanaka, Y.; Miyake, R.; Kikkawa, U.; Nishizuka, Y. J. Biochem. 1986, 99, 257-261.
50. Cheng, Y.; Prusoff, W. H. Biochem. Pharmacol. 1973, 22, 3099-3108.